99 related articles for article (PubMed ID: 26175398)
1. Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis.
Yang Z; Ye P; Xu Q; Lu Y; Tang B; Wang Q; Chen S; Chen X
Discov Med; 2015 Jun; 19(107):409-18. PubMed ID: 26175398
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of serum gamma-glutamyl transferase before transcatheter arterial chemoembolization in patients with intermediate hepatocellular carcinoma].
Chang Z; Wang M; Liu F; Song P; Duan F; Wang Z
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(9):667-9. PubMed ID: 24842205
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
4. γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma.
Ma H; Zhang L; Tang B; Wang Y; Chen R; Zhang B; Chen Y; Ge N; Wang Y; Gan Y; Ye S; Ren Z
Ann Surg Oncol; 2014 Sep; 21(9):3084-9. PubMed ID: 24748164
[TBL] [Abstract][Full Text] [Related]
5. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
Zhang Q; Jiao X
Comput Math Methods Med; 2021; 2021():9809990. PubMed ID: 34845414
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Zhang JB; Chen Y; Zhang B; Xie X; Zhang L; Ge N; Ren Z; Ye SL
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):787-93. PubMed ID: 21730869
[TBL] [Abstract][Full Text] [Related]
7. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
Fu SJ; Zhao Q; Ji F; Chen MG; Wu LW; Ren QQ; Guo ZY; He XS
Sci Rep; 2016 Jul; 6():28835. PubMed ID: 27381639
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma.
Zhang LX; Lv Y; Xu AM; Wang HZ
BMC Cancer; 2019 Aug; 19(1):841. PubMed ID: 31455253
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
[TBL] [Abstract][Full Text] [Related]
10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of serum gamma-glutamyltransferase levels in patients with hepatocellular carcinoma.
Sun L; Wang R; Gao FY; Li YX; Geng MF; Chen JL; Ye XQ; Li XS; Yang X; Wan G; Yang ZY; Wang XB
Neoplasma; 2017; 64(3):444-452. PubMed ID: 28253724
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
Lin CY; Kuo CS; Lu CL; Wu MY; Huang RF
Nutr Cancer; 2010; 62(2):190-7. PubMed ID: 20099193
[TBL] [Abstract][Full Text] [Related]
14. Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.
Xu XS; Wan Y; Song SD; Chen W; Miao RC; Zhou YY; Zhang LQ; Qu K; Liu SN; Zhang YL; Dong YF; Liu C
World J Gastroenterol; 2014 Aug; 20(31):10944-52. PubMed ID: 25152598
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum 14-3-3 beta in patients with hepatocellular carcinoma.
Lin H; Jiao X; Yu B; Du J; Xu H; Dong A; Wan C
Cancer Biomark; 2017 Aug; 20(2):143-150. PubMed ID: 28869445
[TBL] [Abstract][Full Text] [Related]
16. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
18. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
19. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
[TBL] [Abstract][Full Text] [Related]
20. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
